Director Declaration

17 June 2014

BTG plc - Directorship Notification under Listing Rule 9.6.14

Pursuant to the Financial Services Authority Listing Rule 9.6.14(2), BTG plc (the "Company") would like to announce that James O'Shea, who is a non-executive director of the Company, has been appointed as a non-executive director of Cardiome Pharma Corp. (a Canadian based public company whose shares are traded on the NASDAQ Capital Market (CRME) and the Toronto Stock Exchange (COM)) with effect from 16 June, 2014

- ends -

Contact for Queries:

Andy Burrows, Vice President, Corporate and Investor Relations

+44 (0)20 7575 1741